組織バンキングの世界市場予測（2022年～2027年）

世界の組織バンキングの市場規模は、2020年の24億5,400万米ドルから、2027年には33億7,400万米ドルに達し、予測期間中に4.65%のCAGRで成長が予測されています。

研究開発部門における新鮮な標本や組織のニーズが、世界の組織バンキング市場の成長に可能性を与えています。また、細胞・組織再生分野の開発・研究に対する市場企業の投資や、組織バンキングを頼りにしている病院・衛生研究機関が、世界の組織バンキングの市場成長を後押ししています。さらに、慢性疾患の症例が増え、組織再生に基づく治療が行われていることも、世界市場における組織バンキングの市場価値を高めています。加えて、政府や行政機関の支援も、世界の組織バンキング市場の成長に寄与しています。

当レポートでは、世界の組織バンキング市場について調査分析し、市場概要、市場力学、市場分析、競合情勢、企業プロファイルなど、体系的な情報を提供しています。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション

第2章 調査手法

• 調査データ
• 前提条件

第3章 エグゼクティブサマリー

• 調査のハイライト

第4章 市場力学

• 市場促進要因
• 市場抑制要因
• ポーターのファイブフォース分析
  • エンドユーザーの交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 業界における競争企業間の敵対関係
• 業界バリューチェーン分析

第5章 世界の組織バンキング市場分析：組織タイプ別

• イントロダクション
• 角膜
• 皮膚
• 骨
• 心臓弁
• 血液
• 軟部組織
• 臍帯

第6章 世界の組織バンキング市場分析：用途別

• イントロダクション
• 治療
• 研究開発
• その他

第7章 世界の組織バンキング市場分析：地域別

• イントロダクション
• 北米
  • 米国
  • カナダ
  • メキシコ
• 南米
  • ブラジル
  • アルゼンチン
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • その他
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • その他
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • 台湾
  • タイ
  • インドネシア
  • その他

第8章 競合環境と分析

• 主要企業と戦略分析
• 新興企業と市場収益性
• 合併・買収・合意・提携
• ベンダーの競合マトリクス

第9章 企業プロファイル

• Hamilton Company
• IMA Pharma
• Life Link Tissue Bank
• Merck KgaA
• PHC Europe B.V.
• Tata Memorial Hospital-Tissue Bank
• Tecan Group Ltd.
• The PXE International Blood and Tissue Bank
• Thermo Fisher Scientific, Inc.
• TuBaFrost Group
• Versity

The global tissue banking market is evaluated at US$2.454 billion for the year 2020 and is projected to grow at a CAGR of 4.65% to reach a market size of US$3.374 billion by the year 2027.

A tissue bank is considered a certain type of bank that collects fresh specimens and tissue for future needs. The tissue bank is considered one of the leading specimen or tissue storage systems in the world. The medical field and research and development sectors are presently widely seeking the application and help of tissue banks. The need for fresh specimens and tissues in the research and development sector is giving potential to the growth of the global tissue bank market. The market players' investment in the development and research in the cell and tissue regeneration field are also driving the growth of the global tissue bank market. The medical sector and hospitals are also widely seeking the support and assistance of tissue banks for the treatment of certain chronic disorders. Hospitals and health research institutions relying on tissue banks are boosting the market growth of global tissue banks. The rising cases of chronic diseases like cancer etc. and their treatment based on tissue regeneration are also boosting the market value of tissue banks in the global market. The support offered by governments and government organizations is also contributing to the growth of the global tissue banking market.

The recent outbreak of the COVID-19 pandemic has adversely affected the market growth of the global tissue banking market. The ongoing research and developments conducted on tissues were halted due to the lockdowns and strict COVID-19 restrictions imposed by the government in order to prevent the spread of the coronavirus. The focus of the government and the medical field on preventing COVID spread resulted in less focus on and slow growth of the global tissue banking market in the pandemic period. The limited availability of practitioners and employees in the tissue banking sector also restricted the growth of the global tissue banking market to a certain extent. The high economic crisis that arose due to the COVID-19 pandemic also negatively influenced the economic stability of countries, restricting the growth of the tissue banking sector in each country, as the tissue banking systems have high expenditure and maintenance costs.

The demand for tissues for the treatment of chronic diseases

The rising demand for tissues for treating chronic diseases is increasing the market value of the global tissue banking sector. A tissue bank is a collection of various specimens and fresh tissues and is a relatively new discovery in the medical field that employs tissue for the treatment of chronic diseases and is boosting the growth of the global tissue banking system. According to the "American Association of Tissue Banks", the tissue banking network in the United States is exhibiting steady growth, with approximately 58 accredited tissue banks working in the United States alone. The tissue banks working in the United States are also properly certified and accredited by the FDA (Food and Drug Administration) of the United States. The government of the U.S. has been encouraging the use of tissue banks. According to the report of AATB (American Association of Tissue Banks), blood tissues or blood cells account for the major share of the global tissue banking market. The need for fresh specimens and the tissue in the treatment of chronic disorders and regeneration of tissue cells is driving the growth of the global tissue banking market.

Rising research and development

The growing trend of research and developments in tissue regeneration and the use of tissue in efficiently treating chronic diseases is boosting the growth of the global tissue banking market. Discoveries of stem cells in developing any other tissue is one of the latest innovations in the medical or health research sector. The discoveries like stem cells and others are fuelling the market growth of tissue banking in the global market. The investment of major players like Allergan and Hamilton Companies is boosting the applications and developments in tissue engineering. The wide research and developments in tissue engineering and employing tissue for treating chronic diseases are contributing to the market growth.

North America has the largest market share

Geographically, the North American region is has the largest share in the global tissue banking market. The presence of a large number of tissue banks and increasing research and development in the tissue engineering sector is leading to growth in the North American region in the tissue banking market. The presence of major market players and the rising number of chronic diseases are also driving the market growth in the North American tissue banking market.

Market Segmentation

• By Tissue Type

Cornea

Skin

Bones

Heart Valves

Blood

Soft Tissues

Umbilical Cord

• By Application

Therapeutic

Research and development

Others

• By Geography

North America

• USA
• Canada
• Mexico

South America

• Brazil
• Argentina
• Others

Europe

• Germany
• France
• UK
• Others

Middle East and Africa

• Saudi Arabia
• UAE
• Others

Asia Pacific

• China
• India
• Japan
• South Korea
• Taiwan
• Thailand
• Indonesia
• Others

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition
• 1.2. Market Segmentation

2. Research Methodology

• 2.1. Research Data
• 2.2. Assumptions

3. Executive Summary

• 3.1. Research Highlights

4. Market Dynamics

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porters Five Forces Analysis
  • 4.3.1. Bargaining Power of End-Users
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. Global Tissue Banking Market Analysis, by Tissue Type

• 5.1. Introduction
• 5.2. Cornea
• 5.3. Skin
• 5.4. Bones
• 5.5. Heart Valves
• 5.6. Blood
• 5.7. Soft Tissues
• 5.8. Umbilical Cord

6. Global Tissue Banking Market Analysis, by Application 

• 6.1. Introduction
• 6.2. Therapeutic
• 6.3. Research and development
• 6.4. Others

7. Global Tissue Banking Market Analysis, by Geography

• 7.1. Introduction
• 7.2. North America
  • 7.2.1. USA
  • 7.2.2. Canada
  • 7.2.3. Mexico
• 7.3. South America
  • 7.3.1. Brazil
  • 7.3.2. Argentina
  • 7.3.3. Others
• 7.4. Europe
  • 7.4.1. Germany
  • 7.4.2. France
  • 7.4.3. UK
  • 7.4.4. Others
• 7.5. Middle East and Africa
  • 7.5.1. Saudi Arabia
  • 7.5.2. UAE
  • 7.5.3. Others
• 7.6. Asia Pacific
  • 7.6.1. China
  • 7.6.2. India
  • 7.6.3. Japan
  • 7.6.4. South Korea
  • 7.6.5. Taiwan
  • 7.6.6. Thailand
  • 7.6.7. Indonesia
  • 7.6.8. Others

8. Competitive Environment and Analysis

• 8.1. Major Players and Strategy Analysis
• 8.2. Emerging Players and Market Lucrativeness
• 8.3. Mergers, Acquisitions, Agreements, and Collaborations
• 8.4. Vendor Competitiveness Matrix

9. Company Profiles 

• 9.1. Hamilton Company
• 9.2. IMA Pharma
• 9.3. Life Link Tissue Bank
• 9.4. Merck KgaA
• 9.5. PHC Europe B.V.
• 9.6. Tata Memorial Hospital - Tissue Bank
• 9.7. Tecan Group Ltd.
• 9.8. The PXE International Blood and Tissue Bank
• 9.9. Thermo Fisher Scientific, Inc.
• 9.10. TuBaFrost Group
• 9.11. Versity